Got questions? Contact us.
Still can’t find your answers here? Contact our molecular team to get answers faster.
Many types and species of microorganisms are causative of infections in humans and the specialized tests that we perform can identify some of these. Our tests utilize real time PCR (qPCR) amplification to detect the presence of a microorganism in a specimen by amplifying the genomic material of the organism(s). The microorganism(s) we test for are listed below in Test Menus. Amplification and detection are performed using a the Applied Biosystems™ QuantStudio™ 7 Flex real time PCR system which includes the QuantStudio™ Real-Time PCR Software. Real time PCR amplification is performed using validated multiplex real-time PCR assays utilizing hydrolysis probe technology to identify target nucleic acids. The primer/probes are pre-dispensed into a qPCR plate to be used in conjunction with nucleic acids extracted from a variety of sample types and include essential control assays to ensure dependable results.
These methodologies allow Southwest Labs to rapidly and simultaneously test for many infectious organisms as well as some of the most common genes known to confer possible resistance to antibiotics. Given this, all of these possible tests return an independent binary result: present or absent. For this reason, it is not possible for Southwest labs to determine which of two (or more) detected bacterial pathogens contain any simultaneously detected antibiotic resistance gene (s) from the same specimen. Therefore, in polymicrobial specimen results of this type, medical providers could assume the antibiotic resistance genes were present in all detected bacterial microorganisms when they are selecting a treatment as a means of reducing the likelihood of antibiotic failure due to antibiotic resistance.
Our tests can simultaneously detect the possible presence of many infectious organisms as well as some of the most common genes known to confer possible resistance to antibiotics. As a courtesy to medical providers, our tests result software utilizes these data points to generate some clinical treatment information for consideration by the ordering provider. The resources used to compile this information were the Sanford Guide™ the Comprehensive Antibiotic Resistance Database™, UpToDate™, The Infectious Diseases Society of America (IDSA), and the advice of experienced medical professionals. However, any and all information relating to possible treatment of infectious disease(s) provided by Southwest Labs is done so exclusively as an informational courtesy alone. Any and all decisions to treat our not treat an infection and/or what treatments to use for an infection(s) must be made at the sole direction of the medical provider using clinical judgement and information. Southwest Labs does not make medical diagnoses and does not provide medical treatment. Southwest Labs is not responsible for any treatment decision(s) made by ordering providers.
Bacterial Targets:
Acinetobacter baumanii
Bordetella pertussis, parapertussis, bronchiseptica
Chlamydia pneumoniae
Enterobacter cloacae complex / Klebsiella (Enterobacter) aerogenes
Escherichia coli
Haemophilus influenzae
Klebsiella oxytoca
Klebsiella pneumoniae
Legionella pneumophila
Moraxella catarrhalis
Mycoplasma pneumoniae
Nocardia spp
Proteus mirabilis, vulgaris
Pseudomonas aeruginosa
Serratia marcescens
Staphylococcus aureus
Streptococcus agalactiae (Group B)
Streptococcus pneumoniae
Fungal Targets:
Aspergillus spp. (flavus, niger, terreus, fumigatus)
Candida albicans, parapsilosis, tropicalis
Candida glabrata
Viral Targets:
Adenovirus
Coronavirus (229E, HKU1, NL63, and OC43)
COVID-19 Coronavirus (SARS-CoV-2)
Cytomegalovirus
Enterovirus D68
Human metapneumovirus
Influenza virus A, B
Parainfluenza virus (types 1, 2, 3, 4)
Respiratory syncytial virus
Rhinovirus / Enterovirus
Antiobiotic Resistance Genes:
ACT/MIR, FOX, ACC Groups
CTX-M Groups
DfrA1, DfrA5, Sul1, Sul2, Sul3
ermA, ermB, erm C, mefA
IMP, NDM, VIM Groups
mecA, mecC
OXA48, OXA51
qnrA1/A2, qnrB2, qnrS
SVH, KPC Groups
tetB, tetM
vanA, vanB
BACTERIAL TARGETS:
Chlamydia pneumoniae
Fusobacterium nucleatum / Fusobacterium necrophorum
Mycoplasma pneumoniae
Streptococcus dysgalactiae subsp. Equisimilis
Streptococcus pyogenes (Group A)
FUNGAL TARGETS:
Candida albicans, parapsilosis, tropicalis
Candida glabrata
VIRAL TARGETS:
Adenovirus
Coronavirus (229E, HKU1, NL63, and OC43)
COVID-19 Coronavirus (SARS-CoV-2)
Enterovirus D68
Epstein-Barr Virus
HSV Type 1 & 2
Human metapneumovirus
Influenza virus A, B
Parainfluenza virus (types 1, 2, 3, 4)
Respiratory syncytial virus
Rhinovirus / Enterovirus
ANTIBIOTIC RESISTANCE GENES:
ACT/MIR, FOX, ACC Groups
CTX-M Groups
DfrA1, DfrA5, Sul1, Sul2, Sul3
ermA, ermB, erm C, mefA
IMP, NDM, VIM Groups
mecA, mecC
OXA48, OXA51
qnrA1/A2, qnrB2, qnrS
SVH, KPC Groups
tetB, tetM
vanA, vanB
BACTERIAL TARGETS:
Fusobacterium nucleatum / Fusobacterium necrophorum
Haemophilus influenzae
Moraxella catarrhalis
Nocardia spp
Pseudomonas aeruginosa
Staphylococcus aureus
Streptococcus pneumoniae
FUNGAL TARGETS:
Aspergillus spp. (flavus, niger, terreus, fumigatus)
Candida albicans, parapsilosis, tropicalis
Candida glabrata
ANTIBIOTIC RESISTANCE GENES:
ACT/MIR, FOX, ACC Groups
CTX-M Groups
DfrA1, DfrA5, Sul1, Sul2, Sul3
ermA, ermB, erm C, mefA
IMP, NDM, VIM Groups
mecA, mecC
OXA48, OXA51
qnrA1/A2, qnrB2, qnrS
SVH, KPC Groups
tetB, tetM
vanA, vanB
VIRAL TARGETS:
Adenovirus
Coronavirus (229E, HKU1, NL63, and OC43)
COVID-19 Coronavirus (SARS-CoV-2)
Enterovirus D68
Human metapneumovirus
Influenza virus A, B
Parainfluenza virus (types 1, 2, 3, 4)
Respiratory syncytial virus
VIRAL TARGETS:
Influenza A and B
Respiratory Syncytial Virus
SARS-CoV-2
BACTERIAL TARGETS:
Acinetobacter baumannii
Chlamydia trachomatis
Citrobacter freundii
Enterobacter cloacae complex
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Klebsiella aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
Morganella morganii
Mycoplasma genitalium
Mycoplasma hominis
Neisseria gonorrhoeae
Proteus mirabilis
Proteus vulgaris
Pseudomonas aeruginosa
Serratia marcescens
Staphylococcus aureus
Staphylococcus epidermidis, haemolyticus, lugdunensis
Staphylococcus saprophyticus
Streptococcus agalactiae (Group B)
Streptococcus pyogenes (Group A)
Ureaplasma parvum
Ureaplasma urealyticum
FUNGAL TARGETS:
Candida albicans, parapsilosis, tropicalis
Candida glabrata
Candida krusei
PARASITIC TARGETS:
Trichomonas vaginalis
ANTIBIOTIC RESISTANCE GENES:
ACT/MIR, FOX, ACC Groups
CTX-M Groups
DfrA1, DfrA5, Sul1, Sul2, Sul3
ermA, ermB, erm C, mefA
IMP, NDM, VIM Groups
mecA, mecC
OXA48, OXA51
qnrA1/A2, qnrB2, qnrS
SVH, KPC Groups
tetB, tetM
vanA, vanB
BACTERIAL TARGETS:
Acinetobacter baumannii
Citrobacter freundii
Enterobacter cloacae complex
Enterococcus faecalis
Enterococcus faecium
Escherichia coli
Klebsiella aerogenes
Klebsiella oxytoca
Klebsiella pneumoniae
Morganella morganii
Proteus mirabilis
Proteus vulgaris
Pseudomonas aeruginosa
Serratia marcescens
Staphylococcus aureus
Staphylococcus epidermidis, haemolyticus, lugdunensis
Staphylococcus saprophyticus
Streptococcus agalactiae (Group B)
Streptococcus pyogenes (Group A)
FUNGAL TARGETS:
Candida albicans, parapsilosis, tropicalis
Candida glabrata
Candida krusei
ANTIBIOTIC RESISTANCE GENES:
ACT/MIR, FOX, ACC Groups
CTX-M Groups
DfrA1, DfrA5, Sul1, Sul2, Sul3
ermA, ermB, erm C, mefA
IMP, NDM, VIM Groups
mecA, mecC
OXA48, OXA51
qnrA1/A2, qnrB2, qnrS
SVH, KPC Groups
tetB, tetM
vanA, vanB
BACTERIAL TARGETS:
Atopobium vaginae
BVAB 2, 3 (bacterial vaginosis associated bacteria 2, 3)
Chlamydia trachomatis
Gardnerella vaginalis
Megasphaera (types 1, 2)
Mobiluncus spp.
Mycoplasma genitalium
Mycoplasma hominis
Neisseria gonorrhoeae
Ureaplasma parvum
Ureaplasma urealyticum
FUNGAL TARGETS:
Candida albicans, parapsilosis, tropicalis
Candida glabrata (Nakaseomyces glabratus)
Candida krusei (Pichia kudriavzevii)
PARASITIC TARGETS:
Trichomonas vaginalis
VIRAL TARGETS:
Herpes simplex virus Type 1 and 2
HPV Types 16 and 18
ANTIBIOTIC RESISTANCE GENES:
ACT/MIR, FOX, ACC Groups
CTX-M Groups
DfrA1, DfrA5, Sul1, Sul2, Sul3
ermA, ermB, erm C, mefA
IMP, NDM, VIM Groups
mecA, mecC
OXA48, OXA51
qnrA1/A2, qnrB2, qnrS
SVH, KPC Groups
tetB, tetM
vanA, vanB
BACTERIAL TARGETS:
Chlamydia trachomatis
Mycoplasma genitalium
Mycoplasma hominis
Neisseria gonorrhoeae
Ureaplasma parvum
Ureaplasma urealyticum
VIRAL TARGETS:
Herpes simplex virus 1 and 2
HPV Types 16 and 18
PARASITIC TARGETS:
Trichomonas vaginalis
ANTIBIOTIC RESISTANCE GENES:
ACT/MIR, FOX, ACC Groups
CTX-M Groups
DfrA1, DfrA5, Sul1, Sul2, Sul3
ermA, ermB, erm C, mefA
IMP, NDM, VIM Groups
mecA, mecC
OXA48, OXA51
qnrA1/A2, qnrB2, qnrS
SVH, KPC Groups
tetB, tetM
vanA, vanB
Ana Valdez
Chief of Laboratory Operations
- 505-919-7818 x1912
- ana.v@southwestlab.com
- 4261 Balloon Park Rd, NE
Jennine Griffith-Vandi MB(ASCP)CM
Director of Pre-Analytic & Molecular Operations
- 505-609-5227 x 202
- jennine.g@southwestlab.com
- 4261 Balloon Park Rd, NE
Southwest Labs Regional Sales Representatives
- 505-609-5227
- sales@southwestlab.com
- 4261 Balloon Park Rd, NE